ROVI.MC : Summary for LABORATORIOS FARMACEUTICOS ROVI - Yahoo Finance

U.S. Markets closed

LABORATORIOS FARMACEUTICOS ROVI (ROVI.MC)


MCE - MCE Delayed Price. Currency in EUR
Add to watchlist
11.88+0.16 (+1.37%)
At close: 11:35 AM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close11.72
Open11.72
Bid11.80 x 8400
Ask12.07 x 15000
Day's Range11.72 - 12.07
52 Week Range10.80 - 15.38
Volume11,713
Avg. Volume10,935
Market Cap585.67M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors
    Capital Cube2 months ago

    Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 50. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look
    Capital Cube5 months ago

    Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look

    Laboratorios Farmaceúticos Rovi SA relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 50.Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT).Relative ValuationLaboratorios Farmaceúticos […] (Read more...) The post Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look appeared first on CapitalCube.

  • Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors
    Capital Cubelast year

    Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors

    Laboratorios Farmaceúticos Rovi SA relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 53.Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT).Relative ValuationLaboratorios Farmaceúticos (Read more...) The post Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors appeared first on CapitalCube.